南京公用(000421.SZ):累計收到政府補助2261.37萬元
格隆匯5月9日丨南京公用(000421.SZ)公佈,自2023年2月至披露日,公司累計收到政府補助2261.37萬元。具體如下:
與資產相關的政府補助:公司收到購車補貼830.00萬元,充電設施建設補貼92.40萬元,佔公司最近一期經審計淨資產的0.32%,計入“遞延收益”科目。
與收益相關的政府補助:安慶中北巴士有限公司收到安慶市財政局運營補貼1,300.00萬元,計入“其他收益”科目;公司收到税費減免、其他運營補貼38.28萬元,計入“其他收益”科目;公司收到穩崗補貼等0.69萬元,計入“營業外收入”科目。上述金額合計佔公司最近一期經審計淨利潤的22.12%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.